检索结果 - Sumimasa Nagai

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan

    Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan 由 Sumimasa Nagai

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

    Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies 由 Gita Thanarajasingam, Lori M. Minasian, Frédéric Baron, Franco Cavalli, R. Angelo de Claro, Amylou C. Dueck, Tarec Christoffer El‐Galaly, Neil Everest, Jan Geißler, Christian Gisselbrecht, John G. Gribben, Mary M. Horowitz, S. Percy Ivy, Caron A. Jacobson, Armand Keating, Paul G. Kluetz, Aviva C. Krauss, Yok‐Lam Kwong, Richard F. Little, François-Xavier Mahon, Matthew J. Matasar, María‐Victoria Mateos, Kristen McCullough, Robert S. Miller, Mohamad Mohty, Philippe Moreau, Lindsay M. Morton, Sumimasa Nagai, Simon Rule, Jeff A. Sloan, Pieter Sonneveld, Carrie A. Thompson, Kyriaki Tzogani, Flora E. van Leeuwen, Galina Velikova, Diego Villa, John R. Wingard, Sophie Wintrich, John F. Seymour, Thomas M. Habermann

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:

检索工具: